CCL5 and neoplasm: Combining these findings with previous research indicating that RANTES enhances antitumor immunity in in vivo models,46 we speculate that HRG not only confers NK cell‐mediated antitumor immunity but also induces the migration of CTLs to tumor cells via the activity of RANTES, which are released from NK cells.